Get the Stockscreener App
165.75
1.12%
-2.44
Natera Inc stock is traded at $165.75, with a volume of 119.16K.
It is down -1.12% in the last 24 hours and down -0.69% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$168.19
Open:
$167.5
24h Volume:
119.16K
Relative Volume:
0.09
Market Cap:
$20.65B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-94.18
EPS:
-1.76
Net Cash Flow:
$-43.68M
1W Performance:
-4.08%
1M Performance:
-0.69%
6M Performance:
+36.42%
1Y Performance:
+138.40%
1-Day Range:
$165.71
$168.88
1-Week Range:
$165.34
$180.41
52-Week Range:
$69.74
$183.00
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
166.07 | 20.65B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
538.05 | 205.72B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
212.21 | 149.54B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
136.63 | 39.02B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
460.12 | 37.08B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
194.98 | 34.17B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Rhumbline Advisers Sells 1,620 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Vontobel Holding Ltd. Lowers Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Natera (NTRA) to Release Earnings on Wednesday - MarketBeat
Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Alberta Investment Management Corp Sells 5,011,459 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Bought by Van ECK Associates Corp - MarketBeat
Natera (NTRA) Surged on Blowout Quarterly Results - Insider Monkey
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Principal Financial Group Inc. - MarketBeat
Chevy Chase Trust Holdings LLC Boosts Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Banque Pictet & Cie SA Decreases Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025 - Business Wire
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat
Natera (NTRA) Recently Broke Out Above the 20-Day Moving Average - MSN
Quent Capital LLC Sells 3,008 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera CEO Steven Chapman sells $12.96m in stock - MSN
Natera CFO Michael Burkes sells $4.28m in stock - MSN
Natera's chief legal officer sells $3.64 million in stock - MSN
11,294 Shares in Natera, Inc. (NASDAQ:NTRA) Bought by Guided Capital Wealth Management LLC - MarketBeat
Allspring Global Investments Holdings LLC Sells 115,810 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Stock Holdings Lowered by abrdn plc - MarketBeat
Empowered Funds LLC Decreases Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera stock holds at $175 target, Raymond James sees progress - MSN
Sumitomo Mitsui Trust Group Inc. Purchases 69,455 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Canaccord maintains $180 target on Natera stock post-NCCN update - MSN
Mirae Asset Global Investments Co. Ltd. Sells 42,869 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Lecap Asset Management Ltd. Sells 3,150 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
John Fesko Sells 663 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat
Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj - CNBC
October 17th Options Now Available For Natera (NTRA) - Nasdaq
Natera, Inc. Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Marketscreener.com
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection - StockTitan
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Yahoo Finance
Chicago Partners Investment Group LLC Invests $297,000 in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera president sells $290,120 in common stock - MSN
Natera, Inc. (NASDAQ:NTRA) CFO Sells $7,694,633.76 in Stock - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Calamos Advisors LLC - MarketBeat
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):